C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

[1]  D. Maraganore,et al.  Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease , 2014, Neurology.

[2]  Kevin F. Bieniek,et al.  Expanded C9ORF72 hexanucleotide repeat in depressive pseudodementia. , 2014, JAMA neurology.

[3]  Nick C Fox,et al.  Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria , 2014, The Lancet Neurology.

[4]  C. van Broeckhoven,et al.  A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories , 2014, Journal of Medical Genetics.

[5]  J. Hodges,et al.  Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile. , 2014, JAMA neurology.

[6]  P. Gleeson,et al.  C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking , 2014, Human molecular genetics.

[7]  J. Kirby,et al.  The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype , 2014, Acta Neuropathologica.

[8]  P. McColgan,et al.  C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies , 2014, Neurology.

[9]  G. Forloni,et al.  C9ORF72 hexanucleotide repeat number in frontotemporal lobar degeneration: a genotype-phenotype correlation study. , 2013, Journal of Alzheimer's disease : JAD.

[10]  E. Kremmer,et al.  Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins , 2013, Acta Neuropathologica.

[11]  L. Petrucelli,et al.  Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study , 2013, The Lancet Neurology.

[12]  C. Broeckhoven,et al.  Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum , 2013, Trends in Neurosciences.

[13]  Z. Zou,et al.  Screening for C9orf72 repeat expansions in Chinese amyotrophic lateral sclerosis patients , 2013, Neurobiology of Aging.

[14]  A. Higginbottom,et al.  Simultaneous and independent detection of C9ORF72 alleles with low and high number of GGGGCC repeats using an optimised protocol of Southern blot hybridisation , 2013, Molecular Neurodegeneration.

[15]  C. Ki,et al.  Analysis of the C9orf72 hexanucleotide repeat expansion in Korean patients with familial and sporadic amyotrophic lateral sclerosis , 2013, Neurobiology of Aging.

[16]  E. Kremmer,et al.  The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS , 2013, Science.

[17]  P. Johannsen,et al.  Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease , 2013, Clinical genetics.

[18]  Nick C Fox,et al.  Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. , 2013, American journal of human genetics.

[19]  C. van Broeckhoven,et al.  Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort. , 2013, JAMA neurology.

[20]  C. Broeckhoven,et al.  hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations , 2013, Acta Neuropathologica.

[21]  Timothy P. Levine,et al.  The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs , 2013, Bioinform..

[22]  L. Aravind,et al.  Discovery of Novel DENN Proteins: Implications for the Evolution of Eukaryotic Intracellular Membrane Structures and Human Disease , 2012, Front. Gene..

[23]  P. S. St George-Hyslop,et al.  Investigation of c9orf72 in 4 neurodegenerative disorders. , 2012, Archives of neurology.

[24]  F. Jessen,et al.  A Pan-European Study of the C9orf72 Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability, and Intermediate Repeats , 2012, Human mutation.

[25]  A. Singleton,et al.  Large C9orf72 repeat expansions are not a common cause of Parkinson's disease , 2012, Neurobiology of Aging.

[26]  Hitoshi Takahashi,et al.  Japanese amyotrophic lateral sclerosis patients with GGGGCC hexanucleotide repeat expansion in C9ORF72 , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[27]  Nick C Fox,et al.  Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions , 2012, Alzheimer's Research & Therapy.

[28]  D. Geschwind,et al.  Frontotemporal dementia due to C9ORF72 mutations , 2012, Neurology.

[29]  P. Tsai,et al.  A hexanucleotide repeat expansion in C9ORF72 causes familial and sporadic ALS in Taiwan , 2012, Neurobiology of Aging.

[30]  B. Boeve,et al.  Cognitive and behavioral features of c9FTD/ALS , 2012, Alzheimer's Research & Therapy.

[31]  Michelle K. Lupton,et al.  The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder , 2012, European Journal of Human Genetics.

[32]  Janel O. Johnson,et al.  Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study , 2012, The Lancet Neurology.

[33]  F. Marrosu,et al.  Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. , 2012, Brain : a journal of neurology.

[34]  C. Jack,et al.  Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics , 2012, Brain : a journal of neurology.

[35]  David T. Jones,et al.  Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 , 2012, Brain : a journal of neurology.

[36]  S. Pereson,et al.  A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study , 2012, The Lancet Neurology.

[37]  A. Singleton,et al.  Repeat expansion in C9ORF72 in Alzheimer's disease. , 2012, The New England journal of medicine.

[38]  A. Eisen,et al.  Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p , 2012, Acta Neuropathologica.

[39]  T. Ferman,et al.  Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72 , 2011, Acta Neuropathologica.

[40]  David Heckerman,et al.  A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.

[41]  Bruce L. Miller,et al.  Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.

[42]  Bruce L. Miller,et al.  Frontotemporal lobar degeneration , 2010, CNS drugs.

[43]  J R Hodges,et al.  The prevalence of frontotemporal dementia , 2002, Neurology.

[44]  O. Hardiman,et al.  Incidence and prevalence of ALS in Ireland, 1995–1997 , 1999, Neurology.

[45]  S. Chin,et al.  Amyotrophy in prion diseases. , 2000, Archives of neurology.